CASRdb: calcium-sensing receptor locus-specific database for mutations causing familial (benign) hypocalciuric hypercalcemia, neonatal severe hyperparathyroidism, and autosomal dominant hypocalcemia
- 1 August 2004
- journal article
- databases
- Published by Hindawi Limited in Human Mutation
- Vol. 24 (2) , 107-111
- https://doi.org/10.1002/humu.20067
Abstract
Familial hypocalciuric hypercalcemia (FHH) is caused by heterozygous loss‐of‐function mutations in the calcium‐sensing receptor (CASR), in which the lifelong hypercalcemia is generally asymptomatic. Homozygous loss‐of‐function CASR mutations manifest as neonatal severe hyperparathyroidism (NSHPT), a rare disorder characterized by extreme hypercalcemia and the bony changes of hyperparathyroidism, which occur in infancy. Activating mutations in the CASR gene have been identified in several families with autosomal dominant hypocalcemia (ADH), autosomal dominant hypoparathyroidism, or hypocalcemic hypercalciuria. Individuals with ADH may have mild hypocalcemia and relatively few symptoms. However, in some cases seizures can occur, especially in younger patients, and these often happen during febrile episodes due to intercurrent infection. Thus far, 112 naturally‐occurring mutations in the human CASR gene have been reported, of which 80 are unique and 32 are recurrent. To better understand the mutations causing defects in the CASR gene and to define specific regions relevant for ligand‐receptor interaction and other receptor functions, the data on mutations were collected and the information was centralized in the CASRdb ( www.casrdb.mcgill.ca), which is easily and quickly accessible by search engines for retrieval of specific information. The information can be searched by mutation, genotype–phenotype, clinical data, in vitro analyses, and authors of publications describing the mutations. CASRdb is regularly updated for new mutations and it also provides a mutation submission form to ensure up‐to‐date information. The home page of this database provides links to different web pages that are relevant to the CASR, as well as disease clinical pages, sequence of the CASR gene exons, and position of mutations in the CASR. The CASRdb will help researchers to better understand and analyze the mutations, and aid in structure–function analyses. Hum Mutat 24:107–111, 2004.Keywords
This publication has 22 references indexed in Scilit:
- Standardizing mutation nomenclature: Why bother?Human Mutation, 2003
- Human Calcium-sensing Receptor GenePublished by Elsevier ,2002
- Identification and Functional Characterization of Novel Calcium-Sensing Receptor Mutations in Familial Hypocalciuric Hypercalcemia and Autosomal Dominant HypocalcemiaJournal of Clinical Endocrinology & Metabolism, 2002
- Extracellular Calcium-sensing Receptor Is Expressed in Rat HepatocytesPublished by Elsevier ,2001
- Extracellular Calcium Sensing and Extracellular Calcium SignalingPhysiological Reviews, 2001
- Cloning and Characterization of Two Promoters for the Human Calcium-sensing Receptor (CaSR) and Changes of CaSR Expression in Parathyroid AdenomasPublished by Elsevier ,2000
- A986S polymorphism of the calcium-sensing receptor and circulating calcium concentrationsThe Lancet, 1999
- Neonatal severe hyperparathyroidism, secondary hyperparathyroidism, and familial hypocalciuric hypercalcemia: Multiple different phenotypes associated with an inactivatingAlu insertion mutation of the calcium-sensing receptor geneAmerican Journal of Medical Genetics, 1997
- Markedly reduced activity of mutant calcium-sensing receptor with an inserted Alu element from a kindred with familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism.Journal of Clinical Investigation, 1997
- Molecular Cloning and Functional Expression of Human Parathyroid Calcium Receptor cDNAsJournal of Biological Chemistry, 1995